Stay updated with breaking news from Primary Endpoint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective,...
Asia Market Update: Asian equity indices trade mixed after Fed decision; AU jobs data beat ests, AU yield curve flattened; European central bank decis
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--Dec 12, 2021--
Biogen said that it is evaluating next steps for tofersen (BIIB067) after acknowledging that the antisense drug missed its primary endpoint in a Phase III trial in people with superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate VALNEVAJuly 19, 2021 GMT Saint-Herblain (France) and New York, NY, July 19, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. (NYSE: PFE), today announced that they have completed recruitment for the Phase 2 trial, VLA15-221, ...